Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Vous n'êtes pas connecté
Researchers have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system’s ability to fight cancer. The team at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, showed promising results for the new therapy in cancer cells in the lab and in mouse lung tumour [...]
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are necessary.
A credit-card-sized chip may soon outsmart cancer. A team led by NYU Tandon School of Engineering’s Weiqiang Chen has developed a miniature device...
A credit-card-sized chip may soon outsmart cancer. A team led by NYU Tandon School of Engineering’s Weiqiang Chen has developed a miniature device...
Melanoma, one of the deadliest forms of skin cancer, affects an estimated 330,000 people worldwide each year and causes nearly 60,000 deaths...
Melanoma, one of the deadliest forms of skin cancer, affects an estimated 330,000 people worldwide each year and causes nearly 60,000 deaths...
An innovative bnano-immune agonist/b has been developed to significantly enhance bimmunotherapy outcomes for medlinkmelanoma/medlink/b, a
A team of international researchers led by King Abdullah University of Science and Technology (KAUST) and including researchers from King Abdulaziz...
A team of international researchers led by King Abdullah University of Science and Technology (KAUST) and including researchers from King Abdulaziz...